Suppr超能文献

干酪样淋巴结炎疫苗:最新和前瞻性策略。

Vaccines for caseous lymphadenitis: up-to-date and forward-looking strategies.

机构信息

Laboratório de Biotecnologia Infecto-Parasitária, Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Campus Universitário s/n, Prédio 19-, Pelotas, RS, 96010-900, Brazil.

Laboratório de Biotecnologia Aplicada a Doenças Infecto-Parasitárias, Centro de Ciências Biológicas e da Saúde, Universidade Federal Rural do Semiárido, Mossoró, Brazil.

出版信息

Appl Microbiol Biotechnol. 2021 Mar;105(6):2287-2296. doi: 10.1007/s00253-021-11191-4. Epub 2021 Mar 2.

Abstract

Caseous lymphadenitis (CLA) is an infectious chronic disease responsible for economic losses in sheep and goat breeding worldwide. CLA has no effective treatment, evidencing the vaccination schedule as the best control strategy. Although some commercial vaccines have been available, none of them provides total protection, which is sometimes insufficient and does not reach the same efficiency when compared in sheep and goats. They also have questionable safety levels and side effects. In light of this, several experimental vaccines are in development in order to improve safety, reproducibility, and protective immune response against the etiologic agent of CLA, Corynebacterium pseudotuberculosis. In this review, we discussed aspects as antigen, adjuvant, routes of administration, protection level, and animal models used in CLA vaccine development, as well the challenges and future perspectives. KEY POINTS: Caseous lymphadenitis (CLA) does not have an appropriate commercial vaccine. Different experimental vaccines are in development aiming to protect against Corynebacterium pseudotuberculosis. An ideal vaccine for CLA is necessary for the disease control.

摘要

干酪性淋巴结炎(CLA)是一种传染性慢性疾病,在世界范围内给绵羊和山羊养殖造成了经济损失。CLA 目前没有有效的治疗方法,疫苗接种计划被证明是最好的控制策略。尽管已经有一些商业疫苗可用,但它们都不能提供完全的保护,其在绵羊和山羊中的效果有时并不理想,而且效率也不相同。它们的安全性和副作用也存在争议。有鉴于此,为了提高针对 CLA 的病原体——假结核棒状杆菌的安全性、重现性和保护性免疫反应,正在开发几种实验性疫苗。在本文中,我们讨论了 CLA 疫苗开发中使用的抗原、佐剂、给药途径、保护水平和动物模型等方面,以及面临的挑战和未来展望。

关键点

  • CLA 没有合适的商业疫苗。

  • 正在开发针对假结核棒状杆菌的不同实验性疫苗,以提供保护。

  • 控制 CLA 需要一种理想的疫苗。

相似文献

1
Vaccines for caseous lymphadenitis: up-to-date and forward-looking strategies.
Appl Microbiol Biotechnol. 2021 Mar;105(6):2287-2296. doi: 10.1007/s00253-021-11191-4. Epub 2021 Mar 2.
5
Antigens of Corynebacterium pseudotuberculosis and prospects for vaccine development.
Expert Rev Vaccines. 2009 Feb;8(2):205-13. doi: 10.1586/14760584.8.2.205.
6
Prevalence of caseous lymphadenitis and usage of caseous lymphadenitis vaccines in sheep flocks.
Aust Vet J. 2003 Jan-Feb;81(1-2):91-5. doi: 10.1111/j.1751-0813.2003.tb11443.x.
8
Control of caseous lymphadenitis.
Vet Clin North Am Food Anim Pract. 2011 Mar;27(1):193-202. doi: 10.1016/j.cvfa.2010.10.019.

引用本文的文献

4
Ovine and Caprine Strains of on Czech Farms-A Comparative Study.
Microorganisms. 2024 Apr 27;12(5):875. doi: 10.3390/microorganisms12050875.
6
Proteomics of Toxigenic Corynebacteria.
Proteomes. 2023 Dec 30;12(1):2. doi: 10.3390/proteomes12010002.
9
A serum NMR metabolomic analysis of the Corynebacterium pseudotuberculosis infection in goats.
Appl Microbiol Biotechnol. 2023 Jul;107(14):4593-4603. doi: 10.1007/s00253-023-12595-0. Epub 2023 May 23.

本文引用的文献

4
Vaccine adjuvants: Why and how.
Hum Vaccin Immunother. 2016 Oct 2;12(10):2709-2711. doi: 10.1080/21645515.2016.1219003.
5
Improving Smallholder Farmer Biosecurity in the Mekong Region Through Change Management.
Transbound Emerg Dis. 2015 Oct;62(5):491-504. doi: 10.1111/tbed.12181. Epub 2013 Nov 8.
6
Large animal models for vaccine development and testing.
ILAR J. 2015;56(1):53-62. doi: 10.1093/ilar/ilv009.
8
Antigens of Corynebacterium pseudotuberculosis and prospects for vaccine development.
Expert Rev Vaccines. 2009 Feb;8(2):205-13. doi: 10.1586/14760584.8.2.205.
10
Corynebacterium pseudotuberculosis and its role in ovine caseous lymphadenitis.
J Comp Pathol. 2007 Nov;137(4):179-210. doi: 10.1016/j.jcpa.2007.07.002. Epub 2007 Sep 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验